Otc - Active Ingredient
glycerin
Vela Shape Resculpting Body Firming Toning Tightening
FDA Label NDC 71588-0007
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Ezekielcosmetic Co., Ltd for the product Vela Shape Resculpting Body Firming Toning Tightening (NDC 71588-0007). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, inactive ingredient, otc - purpose, otc - keep out of reach of children, indications & usage, warnings, dosage & administration, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Inactive Ingredient
wter butylene glycol, caffeine etc
Otc - Purpose
a complete regimen for restorative body shape
Otc - Keep Out Of Reach Of Children
keep out of reach of the children
Indications & Usage
Apply suitable amount of the formula to each are of the body hich can include arms, thighs, stomach and/or buttocks and vigorously massage VELA SHAPE RESCULPTING GEL over the targeted areas in a circular motion until full absorption occurs.
Exertise activity is strongly recommended after the use of the VElA SHAPE RESCULPTING GEL
Warnings
1. If the following symptoms occur after product use, stop using the product immediately and consult a dermatologist (continuous use can exacerbate the symptoms).
1) Occurrence of red spots, swelling, itchiness, and other skin irritation
2) If the symptoms above occur after the application area is exposed to direct sunlight
2. Do not use on open wounds, eczema, and other skin irritations
3. Precaution for Storage and Handling
1) Close the lid after use
2) Keep out of reach of infants and children
3) Do not to store in a place with high/low temperature and exposed to direct sunlight
4. Use as avoiding eye areas.
Dosage & Administration
for external use only
Package Label.Principal Display Panel
Label (Label)
* Please review the disclaimer below.
